by Neha K. Choksi, SmallTech Consulting LLC
February 8, 2010 – Historically, the microfluidics industry has been challenged to achieve a strong return on investment. With the exception of inkjet printing, a key killer application has yet to be identified. This leaves many wondering whether the field has true potential or whether reality is masked in hype. Dr. Holger Becker, co-founder and CSO of microfluidic ChipShop GmbH, shared insights and perspective gained from his nearly 20 years in the industry with the Bay Area MEMS Journal Club on January 28, 2010.
The interest in microfluidics gained steam in the early 1990s with the idea of microTas (micro total analysis systems). But by 2005, many investors became disenchanted with the field because much of their investment had not paid off. Thanks to a better understanding of what microfluidics can do, microfluidics is gaining back its popularity — but with wiser and more open eyes.

Despite his optimism for the industry, Becker encourages realistic expectations for product development. Even with the advances in simulation capability, multiple design iterations should be anticipated. However, in the last few years alone, process know-how has increased significantly. The resistance to adoption is another huge, usually unanticipated hurdle. Microfluidics offers its advantages, but convincing users to switch from existing technologies can be challenging. One pathway to address their reluctance is to make microfluidic systems compatible with existing technology. For example, microfluidic ChipShop has created off-the-shelf items of the same form factor as lab slides, or that can be used with an adapter frame for a microtiter plate format, enabling users to interface with standard laboratory automation.
To create a successful product, Becker emphasizes the need to assemble the right development team. Because of the multidisciplinary nature of the field, the team must include expertise in microfluidics, materials, manufacturability, and a strong understanding of the application. A common mistake that developers make, according to Becker, is spending 80% of their focus on the front-end — when in reality, 80% of the production cost is often back-end processing. Including manufacturing conversations in early stages is critical to the product’s overall feasibility.
Another avoidable pitfall is changing the technology in the middle of production, deviating from that of the initial design. A change in technology, whether it is material, design, or processing, can have large implications on the performance of the device. To ensure that lessons learned during the initial design phase can be transferrable to production, Becker advises that the prototypes be made in a scalable, production-compatible technology.
The opportunities
By being cognizant of the potential pitfalls and acting accordingly, a product developer has many opportunities for success. Becker predicts that market entry is likely to be successful in high-end application niches such as cancer diagnostics. Other opportunities such as food and water diagnostics and veterinary medicine may have lower barriers for entry and the potential for large volume economics. Interest in microfluidics is emerging as a potential key enabler for other products in addition to possible end-user applications.
In addition to direct prospects in microfluidics, Becker sees opportunities to support the field. In many cases, the application does not require the large volumes that the automotive, mobile device, and printing applications offer. Therefore, there is a need for cost-effective, yet flexible manufacturing techniques. Choosing the optimal material is also difficult. A huge variety of polymers are available, but a consolidated standardized database that lists all the particular characteristics that a designer may need would be a very useful tool. Because the material selection is so vast, literature tends to focus on a few "favorite" materials with which the industry is already familiar or experienced, but may, or may not, be optimal for the application. Production worthy quality control process improvements are also necessary in order to reduce screening cycle time of the complex devices that microfluidics entail.
With the right multidisciplinary team, planning for manufacturability, and vigilance towards understanding the application and its barriers to entry, microfluidics has a bright future. In Becker’s words: "Microfluidics has, after following a typical high-tech market acceptance curve with ups and downs, emerged as a true enabler for a multitude of products in the analytical and life science industry. It has taken longer than anticipated, but the light we finally see at the end of the tunnel is definitely not that of an oncoming train."
Neha K. Choksi is a founding member of SmallTech Consulting, LLC, 325 Sharon Park Drive #632, Menlo Park, CA 94025, e-mail [email protected], www.SmallTechConsulting.com.